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Chronic rhinosinusitis (CRS) significantly affects patient quality of life. Medical and surgical 
treatments aim to clinically manage the condition.
Objective: To assess the long-term quality of life and clinical management of CRS in patients 
submitted to endoscopic sinus surgery.
Method: This prospective cross-sectional cohort study enrolled 38 patients and looked into the 
follow-up data of subjects diagnosed with CRS before surgery, three months after surgery, and at 
least two years after surgery. The Sinonasal Outcome Test 22 (SNOT-22) was used to assess response 
to treatment and long-term clinical management of the disease.
Results: Significant improvements in the SNOT-22 scores were seen between the preoperative (61.3) 
and postoperative assessments with three (16.9) and 24 (32.3) months. No statistically significant 
differences were seen when patients with polyps were compared to polyp-free subjects. Few patients 
were controlled in both groups, and 7.89% of the subjects had revision surgery during the study.
Conclusion: Endoscopic sinus surgery significantly improved the quality of life of patients with 
chronic rhinosinusitis. Clinical control of the condition was acceptable, with few patients requiring 
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INTRODUCTION
Chronic rhinosinusitis (CRS) significantly affects 
the quality of life of patients. Cases of CRS may or not be 
associated with nasal polyps. CRS treatment aims to attain 
clinical control of the disease, which is defined as the elimi-
nation or mitigation of patient symptoms to a point where 
subjects are no longer bothered by the disease, possibly 
in combination with a healthy or quasi healthy mucosa 
requiring only the administration of topical medication1.
The severity of symptoms and the impact of the 
disease upon patient quality of life can be assessed 
through the Sinonasal Outcome Test 22 (SNOT-22)2-4. This 
validated tool encompasses all major symptoms included 
in the diagnosis criteria set in the European Position 
Paper on Rhinosinusitis and Nasal Polyps (EPOS) 2012 for 
CRS1. The SNOT-22 is a repeatable tool and the graphic 
representation of test results allows for easy visualization 
of the outcomes of conservative and surgical approaches, 
as well as exacerbations observed during follow-up2-4. 
Morley & Sharp5 compared 15 sinonasal questionnaires 
and concluded that the SNOT-22 is the most adequate tool 
to analyze patients with CRS, including subjects submitted 
to functional endoscopic sinus surgery. The SNOT-22 was 
recommended by the EPOS 2012 as the tool to assess 
patients with CRS1.
This chronic illness is correlated with partially 
explained complex inflammatory mechanisms and 
host-environment interactions, which together explain the 
ineffectiveness of medical and surgical therapies in curing 
patients1. Some authors have looked into quality of life 
and long-term clinical management of the disease6-12, but 
few were able to show improvements in quality-of-life 
test scores7,8,10. This study aimed to assess quality of life 
and long-term clinical management of CRS of patients 
submitted to endoscopic sinus surgery.
METHOD
This prospective longitudinal cohort study included 
chronic rhinosinusitis patients followed up for at least 
two years after endoscopic sinus surgery. The individuals 
included in the study were recruited from the institution’s 
clinic. They were 18 and older and had been diagnosed 
with chronic rhinosinusitis with nasal polyps (CRSwNP) or 
without nasal polyps (CRSsNP) based on the EPOS 2012 
criteria, with indication for surgery. The study was appro-
ved by the Research Ethics Committee and granted permit 
1135/09. Participants signed an informed consent term.
Patients were asked to answer the SNOT-22 ques-
tionnaire before surgery (Preop) and three months after 
surgery (PO3m). In the review patients followed up for 
two years and longer were included (POT). Subjects were 
given a thorough questionnaire that included the SNOT-22, 
an assessment of the clinical management of the disease, 
and reports of revision procedures they were submitted 
to within the timeframe of the study. The chart proposed 
in the EPOS 20121 was used to assess the clinical mana-
gement of CRS (Figure 1).
Figure 1. Assessment of chronic rhinosinusitis and nasal polyp medical 
management. Adapted from EPOS 2012.
The Chi-square test (Fisher’s exact test or Freeman-Halton 
extension of Fisher’s exact test when needed) was used 
to analyze the distribution of genders in the CRSwNP 
and CRSsNP groups. The mean ages of the CRSwNP and 
CRSsNP groups were compared through the unpaired 
t-test. The mean scores in Preop, PO3m and POT of each 
group were compared using the paired t-test. The mean 
scores of the CRSwNP and CRSsNP groups in each of the 
follow-up phases (Preop, PO3m, POT) were compared 
through the unpaired t-test. The distributions of disease 
management and management characteristics for each 
group were compared through the Chi-square test (Fisher’s 
exact test or Freeman-Halton extension of Fisher’s exact 
test when needed). Statistical significance was attributed 
when p < 0.05.
RESULTS
Sixty patients in preoperative care for endoscopic 
sinus surgery diagnosed with CRSwNP or CRSsNP were 
enrolled in the study. After signing informed consent 
terms, they answered the SNOT-22 questionnaire before 
surgery and three months after surgery. Thirty-eight of the 
60 original patients were found two years after surgery 
and were included in the second part of the study. Patient 
characteristics are described on Table 1.
Patients followed up for at least 24 months after sur-
gery were included. There were no statistically significant 
differences between the CRSwNP and CRSsNP groups in 
the different follow-up phases (unpaired t-test: p = 0.72). 
Mean time after surgery in the late follow-up of CRSwNP 
subjects was 29.29 months, with a standard deviation of 
2.34 months, against 28.95 months and a standard deviation 
of 3.54 months in the CRSsNP group. The entire sample 
considered together had a mean POT (late follow-up) of 
29.11 months and a standard deviation of 3.03 months. 
The distribution of POT times can be seen in Figure 2.
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Participants (N/%) 17 44.74 21 55.26 38 100 - -
Females (N/%) 10 58.82 12 57.14 22 57.89
χ2 0.92
Males (N/%) 7 41.18 9 42.86 16 42.11
Age (Mean/SD) 50.59 11.39 42.71 14.68 46.24 13.72 t 0.07
CRSwNP: Chronic rhinosinusitis with nasal polyps; CRSsNP: Chronic rhinosinusitis without nasal polyps; N: Number; %: Percent in each group; 
SD: Standard deviation; χ2: Chi-square; t: Unpaired t-test.
Figure 2. Time distribution of late postoperative follow-up. Minimum 
time after surgery in late postoperative follow-up was 24 months. No 
statistically significant differences were seen between the studied 
groups.
The mean values and standard deviations of SNOT-22 
scores in Preop, PO3m, and POT are presented in Table 2.
Statistically significant differences were seen betwe-
en the Preop, PO3m, and POT measurements in all studied 
groups. No statistically significant differences were seen 
between CRSwNP and CRSsNP when they were compared 
in each of the follow-up phases (Preop, PO3m, POT). 
The before and after surgery measurements are seen in 
Figures 3 to 5 (“Snotograms”).
Table 2. SNOT-22 scores during follow-up.
Groups
CRSwNP CRSsNP Total
Time Mean SD Mean SD Mean SD
Before surgery 58.88 26.14 63.24 22.71 61.29 24.06
Three months after surgery 14.82 12.58 18.67 16.58 16.95 14.86
Late postoperative follow-up 34.06 24.54 30.95 22.23 32.34 23.02
Paired t-test CRSwNP:
Pre vs. PO3m: p < 0.0001*; Pre vs. POT: p = 0.008*; PO3m vs. POT: p = 0.008*
Paired t-test CRSsNP:
Pre vs. PO3m: p < 0.0001*; Pre vs. POT: p = 0.0001*; PO3m vs. POT: p = 0.05*
Paired t-test combined:
Pre vs. PO3m: p < 0.0001*; Pre vs. POT: p = 0.0001*; PO3m vs. POT: p = 0.001*
Unpaired t-test CRSwNP and CRSsNP:
Pre: p = 0.59; PO3m: p = 0.42; POT: p = 0.69
CRSwNP: Chronic rhinosinusitis with nasal polyps; CRSsNP: Chronic rhinosinusitis without nasal polyps; SNOT-22: SinoNasal Outcome Test - 22 
questions; SD: Standard deviation; POT: Late postoperative follow-up.
Figure 3. Snotogram of patients with chronic rhinosinusitis with nasal 
polyps. Dashed line: Mean scores. Marked improvement was seen 
three months after surgery, along with progressive deterioration of the 
mean scores in the long term.
The clinical management of CRSwNP and CRSsNP 
patients is shown in Table 3. No statistically significant 
differences were seen between the groups, but few 
patients were controlled. Three (7.89%) of the 38 patients 
underwent revision surgery during follow-up.
The main complains during late follow-up were 
rhinorrhea (55.26% of the subjects) and hyposmia (50%), 
as seen in Table 4. No statistically significant differences 
were seen between the CRSwNP and CRSsNP groups in 
regards to complaints.
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SNOT-22 and POT scores were statistically better than 
before surgery, indicating the improvement in quality of 
life produced by surgery was sustained in the long term. 
Such late postoperative improvement in quality of life 
contradicted other studies in which SNOT-227 or other 
tests8-11 were used. Even when different parameters were 
used to measure postoperative outcomes, the trends in-
dicated that the disease would maintain a stable course 
in most cases6.
Hopkins et al.7 found mean scores of 42.0 in the 
SNOT-22 before surgery, and statistically significant im-
provements to 25.5 in early postoperative and 27.7 in late 
postoperative follow-up. The scores in postoperative care 
were not statistically different from each other. The mean 
SNOT-22 scores in Preop, PO3m, and POT seen in our 
study were 61.3, 16.9, and 32.3, respectively. The sharper 
drop seen in the preoperative to recent postoperative 
follow-up period may have accounted for the statistically 
significant difference seen between early and late posto-
perative follow-up scores, as late follow-up scores in this 
study were similar to the scores reported by Hopkins et al. 
Statistically significant improvements in quality of life were 
observed two years after surgery, in addition to gradual 
deterioration after three months of surgery, although not 
statistically significant.
Considering the late follow-up clinical management 
of CRS, more than half of the patients were managed in 
acceptable levels (13.2% controlled and 44.7% partially 
controlled). However, 42.1% of the patients were charac-
terized as having their condition uncontrolled, stressing 
the chronic character of CRS. Despite the improvements 
in quality of life, patients are not free of disease and go 
through periods of exacerbation1. The rate of subjects with 
controlled disease found in this study was below expected 
levels. Despite the lack of data on disease clinical manage-
ment based on the EPOS 20121 criteria, Rowe-Jones et al.6 
reported a success rate of clinical management of 89% five 
years after surgery. The authors defined failure as the need 
for at least one course of salvage medication per month 
in two consecutive months. They also found that 36% of 
the patients required additional treatment with steroids 
and antibiotics throughout the five years of postoperative 
follow-up. Li et al.13 used clinical history parameters and 
endoscopic findings to define clinical control, and reported 
a rate of success of 87% within 24 months. Hopkins et al.7 
found that 50% of the patients took medication for sinus 
disease throughout the follow-up period. Published revision 
surgery rates range between 4.2% and 11% within 36 to 60 
months of follow-up6,7; the 7.9% found in our study was 
within that range, despite the shorter duration of the study.
Rhinorrhea (55.3%) and hyposmia (50%) where 
the main complaints present in late follow-up. Nasal 
obstruction is the most prevalent complaint at the time 
of diagnosis1, and is reported by 96.5% of patients with 
Figure 5. Snotogram of mean scores. Despite the absence of statisti-
cally significant differences between groups in each stage of follow-up, 
the scores of the group with nasal polyps were worse in late posto-
perative follow-up.




Characteristic N % N % N %
Controlled 2 11.76 3 14.29 5 13.16
Partially controlled 6 35.29 11 52.38 17 44.74
Uncontrolled 9 52.94 7 33.33 16 42.11
Total 17 100 21 100 38 100
Freeman-Halton extension of Fisher’s exact test: p = 0.25. CRSwNP: 
Chronic rhinosinusitis with nasal polyps; CRSsNP: Chronic rhinosi-
nusitis without nasal polyps; N: Number; %: Percent in each group.
DISCUSSION
Endoscopic sinus surgery improved the quality of 
life of the patients with chronic rhinosinusitis enrolled in 
this study. Despite the worse quality-of-life scores in early 
postoperative follow-up (three months) when compared 
to late postoperative care (24 months and longer), the 
Figure 4. Snotogram of patients with Chronic Rhinosinusitis without 
Nasal Polyps. Dashed line: Mean scores. Marked improvement was 
seen three months after surgery, along with progressive deterioration 
of the mean scores in the long term.
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CRSwNP and 93.5% of subjects with CRSsNP14. Nonethe-
less, patients usually improve from this symptom after 
surgery3,9,15. Posterior rhinorrhea (87.4%)9 and olfactory/
gustatory alterations (90.3% in CRSwNP; 75.7% in CRS-
sNP)14 are next, as also seen in the postoperative data 
gathered in our study, considering that nasal obstruction 
improves to a greater degree than other symptoms. Damm 
et al.9 observed improvements of 84% in nasal obstruction, 
77.8% in rhinorrhea, and 73.2% in hyposmia after sinus 
surgery, as also reported in the review by Chester et al.15, 
in which moderate improvements in facial pain and poste-
rior rhinorrhea and minor improvements in hyposmia and 
headache were described. In view of these findings, the 
prevalences described in our study are within the expected 
range for patients in postoperative follow-up.
Nasal endoscopy and imaging were not used in 
this study to quantify the clinical management of chro-
nic rhinosinusitis. After all, chronic rhinosinusitis is a 
symptom-based condition, and symptom-free patients 
usually do not require additional treatment, even when 
they present minor alterations in endoscopic examina-
tion or mucosal thickening in CT scans of the paranasal 
sinuses16. For that reason, subjective improvement scores 
tend to be higher than their objective counterparts deri-
ved from endoscopic examination, mucociliary clearance, 
odor detection thresholds, and nasal volume assessment6. 
Nonetheless, nasal endoscopy is routinely used in preope-
rative visits to adequately assess and manage patients with 
chronic rhinosinusitis, and CT scans of the paranasal sinu-
ses are reserved for cases of treatment failure and patients 
with multiple symptoms despite adequate postoperative 
medical management16.
Many authors have reported acetylsalicylic acid 
intolerance10,11,17, asthma, depression11, previous sinus 
surgery11,13, peripheral eosinophilia absolute counts above 
520/µL, eosinophilia in the mucosa or mucus17, allergy12,13, 
CRSwNP13 and previous polypectomy12 as predictors of 
poor response to surgery for CRS. Li et al.13 observed a 
success rate of only 52.3% in the treatment of patients 
with recurrent nasal polyps. The authors advocated first 
line therapy with systemic or topical steroids for these 
patients. Matsuwaki et al.17 showed that eosinophilic CRS 
was strongly correlated with recurrence in five years and 
recommended examination of the inflammatory infiltrate 
of the nasal polyps or the paranasal mucosa and long-term 
administration of anti-inflammatory drugs after surgery.
Despite the improvements in symptoms and quality 
of life provided by sinus surgery, it fails to act on cer-
tain aspects of the complex pathophysiology of chronic 
rhinosinusitis and cannot cure patients alone. Long term 
follow-up is of the essence, but proper management can 
be challenging given the significant demand faced by large 
public health care systems and the difficulty performing 
rigorous clinical reviews. The deterioration in clinical 
management and increase on SNOT-22 scores seen two 
years after surgery probably reflect the combination of the 
disease’s natural history and the lack of timely administra-
tion of complementary drug therapy.
CONCLUSION
Endoscopic sinus surgery significantly improved 
the quality of life of patients with chronic rhinosinusitis. 
Patients had acceptable levels of medical management of 
their condition and few required re-operation within two 
years of surgery.
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